FDA Sees More Breakthrough Drugs, Woodcock Says

FDA Sees More Breakthrough Drugs, Woodcock Says Play

Feb. 11 (Bloomberg) -- Janet Woodcock, director of the Food and Drug Administration's Center for Drug Evaluation and Research, talks about the FDA's efforts to speed drugs to market and policies on generic and bio-similar treatments. Woodcock, speaking at Bloomberg's "State of Health Care 2013" summit in New York, also comments on drug shortages. (Source: Bloomberg)

  • On Air Now

    Market Makers Watch Now

  • Next

    Money Clip

blog comments powered by Disqus